Clinical characteristics of 512 eculizumab-naive paroxysmal nocturnal hemoglobinuria patients in China: a single-center observational study

References

• de Latour RP, Mary JY, Salanoubat C, et al. Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood. 2008;112:3099–3106.
   PubMed Web of Science ®Google Scholar
• Schrezenmeier H, Muus P, Socié G, et al. Baseline characteristics and disease burden in patients in the international paroxysmal nocturnal hemoglobinuria registry. Haematologica. 2014;99:922–929.
   PubMed Web of Science ®Google Scholar
• Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993;73:703–711.
   PubMed Web of Science ®Google Scholar
• Brodsky RA, Mukhina G, Li S, et al. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol. 2000;114:459–466.
   PubMed Web of Science ®Google Scholar
• Hansen DL, Moller S, Andersen K, et al. Increasing incidence and prevalence of acquired hemolytic anemias in Denmark, 1980–2016. Clin Epidemiol. 2020;12:497–508.
   PubMed Web of Science ®Google Scholar
• Hillmen P, Lewis SM, Bessler M, et al. Naturnal history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995;333:1253–1258.
   PubMed Web of Science ®Google Scholar
• Rosse WF. Epidemiology of PNH. The Lancet. 1996;348:560.
   PubMed Web of Science ®Google Scholar
• International PNH Interest Group (IPIG). International PNH interest group. Available from: https://www.pnhinterestgroup.org/
   Google Scholar
• Kim JS, Jang JH, Yoon S-S, et al. Distinct subgroups of paroxysmal nocturnal hemoglobinuria(PNH) with cytopenia: results from South Korean National PNH registry. Ann Hematol. 2016;95:125–133.
   PubMed Web of Science ®Google Scholar
• Ueda Y, Obara N, Yonemura Y, et al. Correction to: effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan. Int J Hematol. 2018;108:233–235.
   PubMed Web of Science ®Google Scholar
• Villegas A, Núñez R, Gaya A, et al. Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria results of a retrospective analysis from the Spanish PNH registry. Ann Hematol. 2017;96:1727–1733.
   PubMed Web of Science ®Google Scholar
• Füreder W, Sperr WR, Heibl S, et al. Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH) experience of the Austrian PNH network. Ann Hematol. 2020;99:2303–2313.
   PubMed Web of Science ®Google Scholar
• Ge M, Li X, Shi J, et al. Clinical features and prognostic factors of Asian patients with paroxysmal nocturnal hemoglobinuria: results from a single center in China. Ann Hematol. 2012;91:1121–1128.
   PubMed Web of Science ®Google Scholar
• Fu R, Li L, Liu H, et al. Analysis of clinical characteristics of 92 patients with paroxysmal nocturnal hemoglobinuria: A single institution experience in China. J Clin Lab Anal. 2020;34:e23008.
   PubMed Web of Science ®Google Scholar
• Yu F, Du Y, Han B. A comparative analysis of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria between Asia and Europe/America. Int J Hematol. 2016;103:649–654.
   PubMed Web of Science ®Google Scholar
• Brodsky RA. How I treat paroxysmal nocturnal hemoglobinuria. Blood. 2009;113:6522–6527.
   PubMed Web of Science ®Google Scholar
• Hillmen P, Young NS, Schubert J, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2006;355:1233–1243.
   PubMed Web of Science ®Google Scholar
• Brodsky RA, Young NS, Antonioli E, et al. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood. 2008;111:1840–1847.
   PubMed Web of Science ®Google Scholar
• Kelly RJ, Hill A, Arnold LM, et al. Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood. 2011;117:6786–6792.
   PubMed Web of Science ®Google Scholar
• Krauss JS. Laboratory diagnosis of paroxysmal nocturnal hemoglobinuria. Ann Clin Lab Sci. 2003;33:401–406.
   PubMed Web of Science ®Google Scholar
• Lin G. Paroxysmal nocturnal hemoglobinuria. Chin J Postgraduates Med. 2006;29(31):10–12. doi:10.3760/cma.j.issn.1673-4904.2006.31.004.
   Google Scholar
• Zhao X, Yin X, Zhang L. The epidemiology of the paroxysmal nocturnal hemoglobinuria of Mudanjiang district surveied in ten years. J Mudanjiang Med College. 1997;3:5–7.
   Google Scholar
• Schrezenmeier H, Röth A, Araten DJ, et al. Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH registry. Ann Hematol. 2020;99:1505–1514.
   PubMed Web of Science ®Google Scholar
• Urbano-Ispizua Á, Muus P, Schrezenmeier H, et al. Different clinical characteristics of paroxysmal nocturnal hemoglobinuria in pediatric and adult patients. Haematologica. 2017 Mar;102(3):e76–e79.
   PubMed Web of Science ®Google Scholar
• Hill A, Kelly RJ, Hillmen P. Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood. 2013;121:4985–4996. quiz 5105.
   PubMed Web of Science ®Google Scholar
• Dragoni F, Iori AP, Pignoloni P, et al. Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study. Br J Haematol. 2010;150:492–494.
   PubMed Web of Science ®Google Scholar
• Munoz-Linares C, Ojeda E, Fores R, et al. Paroxysmal nocturnal hemoglobinuria a single Spanish center’s experience over the last 40 yr. Eur J Haematol. 2014;93:309–319.
   PubMed Web of Science ®Google Scholar
• Mercier T, Devos T, Mukovnikova M, et al. Diagnosing nocturnal paroxysmal hemoglobinuria a single-center 4-year experience. Int J Lab Hematol. 2017;39:329–336.
   PubMed Web of Science ®Google Scholar
• Kim JS, Jo D-Y, Jang JH. Distinct subgroups of paroxysmal nocturnal hemoglobinuria (PNH) with cytopenia results from South Korean National PNH registry. J Korean Med Sci. 2016;31:214–221.
   PubMed Web of Science ®Google Scholar
• Ninomiya H, Obara N, Chiba S, et al. Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan. Int J Hematology. 2016;104:548–558.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhang L, Jing L, et al. The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia. Ann Hematol. 2015;94:1105–1110.
   PubMed Web of Science ®Google Scholar
• Lian Y, Shi J, Nie N, et al. Evolution patterns of paroxysmal nocturnal hemoglobinuria clone and clinical implications in acquired bone marrow failure. Exp Hematol. 2019;77:41–50.
   PubMed Web of Science ®Google Scholar
• Pu JJ, Mukhina G, Wang H, et al. Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia. Eur J Haematol. 2011;87:37–45.
   PubMed Web of Science ®Google Scholar
• Du Y, Han B. Advances in hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria. Transplant Cell Ther. 2021;27:301–307.
   PubMedGoogle Scholar
• Kelly RJ, Hochsmann B, Szer J, et al. Eculizumab in pregnant patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2015;373:1032–1039.
   PubMed Web of Science ®Google Scholar
• Hallstensen RF, Bergseth G, Foss S, et al. Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn. Immunobiology. 2015;220:452–459.
   PubMed Web of Science ®Google Scholar
• Chen F, Hu S, Ruan J, et al. Mutational landscape and its clinical significance in paroxysmal nocturnal hemoglobinuria. Blood Cancer J. 2021;11:58.
   PubMed Web of Science ®Google Scholar
• Sun L, Babushok DV. Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria. Blood. 2020;136:36–49.
   PubMed Web of Science ®Google Scholar
• Malcovati L, Cazzola M. The shadowlands of MDS idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP). Hematology Am Soc Hematol Educ Program. 2015;2015:299–307.
   PubMedGoogle Scholar
• Fattizzo B, Ireland R, Dunlop A, et al. Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia. Leukemia. 2021;35:3223–3231.
   PubMed Web of Science ®Google Scholar